Related references
Note: Only part of the references are listed.Microsomal prostaglandin E synthase-1, which is not coupled to a particular cyclooxygenase isoenzyme, is essential for prostaglandin E2 biosynthesis in vascular smooth muscle cells
M. Camacho et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Evidence that a prostanoid produced by cyclo-oxygenase-2 enhances contractile responses of the porcine isolated coronary artery following exposure to lipopolysaccharide
W. Qi et al.
BRITISH JOURNAL OF ANAESTHESIA (2007)
Increased cyclooxygenase-2 expression and prostaglandin-mediated dilation in coronary arterioles of patients with diabetes mellitus
Tamas Szerafin et al.
CIRCULATION RESEARCH (2006)
Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials
Patricia M. Kearney et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities
T Grosser et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human
F Cipollone et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure
TJ Aw et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Interleukin-1β, transforming growth factor-β1, and bradykinin attenuate cyclic AMP production by human pulmonary artery smooth muscle cells in response to prostacyclin analogues and prostaglandin E2 by cyclooxygenase-2 induction and downregulation of adenylyl cyclase isoforms 1, 2, and 4
H El-Haroun et al.
CIRCULATION RESEARCH (2004)
Prostacyclin release and receptor activation: differential control of human pulmonary venous and arterial tone
X Norel et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
COX-2 and beyond: Approaches to prostaglandin inhibition in human disease
G FitzGerald
NATURE REVIEWS DRUG DISCOVERY (2003)
Interleukin-1 beta induces glycosaminoglycan synthesis via the prostaglandin E-2 pathway in cultured human cervical fibroblasts
T Schmitz et al.
MOLECULAR HUMAN REPRODUCTION (2003)
Hypoxic induction of Cox-2 regulates proliferation of human pulmonary artery smooth muscle cells
XD Yang et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2002)
Cyclooxygenase-2 inhibition attenuates lipopolysaccharide-induced cardiovascular failure
K Höcherl et al.
HYPERTENSION (2002)
TNF-α, inefficient by itself, potentiates IL-1β-induced PGHS-2 expression in human pulmonary microvascular endothelial cells:: requirement of NF-κB and p38 MAPK pathways
FA Said et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Cyclo-oxygenase-2 inhibition increases blood pressure in rats
K Höcherl et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: Selective up-regulation of prostacyclin synthesis by COX-2
GE Caughey et al.
JOURNAL OF IMMUNOLOGY (2001)
Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E2-dependent plaque instability
F Cipollone et al.
CIRCULATION (2001)
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.
C Bombardier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Expression of cyclo-oxygenase-2 in human atherosclerotic carotid arteries
V Stemme et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2000)
Fluid shear stress induces lipocalin-type prostaglandin D2 synthase expression in vascular endothelial cells
Y Taba et al.
CIRCULATION RESEARCH (2000)